Now that Ebola is here, it has captured the attention it arguably deserved from us long ago. The latest news is that the patient first diagnosed in the U.S. is in critical condition, and receiving experimental therapy. Lapses in our public health system have been acknowledged, and a scramble to contain the damage, and prevent spread, are playing out as we look on, and worry.
A study out last week in the top-tier journal Nature told us that non-caloric artificial sweeteners (NAS) may contribute to glucose intolerance by mucking up our microbiomes. That's a serious indictment, since these products are intended to help defend against glucose intolerance, and other ills related to diabetes risk and weight gain.